CIK 0001285819
- Non-accelerated filer
- Smaller reporting company
OMEROS CORP
Sign in to watch- Ticker
- OMER
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 911663741
- Phone
- +1 206-676-5000
- Business address
- 201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,648,066
- in 4 filings, $436K under 10b5-1 plans
Net −$1,648,066. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-10-02 | Demopulos Gregory A MD Chairman, CEO & President | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2013-09-25 | Kelbon Marcia S. VP Patent and General Counsel | Grant or award · Stock Option (Right to Buy) | +103,500 | 103,500 | ||
| 2013-09-25 | Demopulos Gregory A MD Chairman, CEO & President | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2013-07-03 | Cable Thomas J. Director | Sale | −5,000 | $5.21 | $26K | 77,067 |
| 2013-05-24 | Hood Leroy E. MD PhD Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2013-05-24 | Demopulos Peter A MD Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2013-05-24 | Cable Thomas J. Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2013-05-24 | Aspiri Ray Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2013-05-24 | HANISH ARNOLD C Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2013-04-11 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion | +5,103 | $0.98 | $5K | 122,250 |
| 2013-04-11 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion · Stock Option (Right to Buy) | −5,103 | 178,774 | ||
| 2013-04-10 | Cable Thomas J. Director | Sale | −5,000 | $3.98 | $20K | 82,067 |
| 2013-01-08 | Cable Thomas J. Director | Sale | −5,000 | $6.19 | $31K | 87,067 |
| 2013-01-04 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion | +10,000 | $0.98 | $10K | 117,147 |
| 2013-01-04 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 183,877 | ||
| 2013-01-04 | Aspiri Ray Director | Purchase | +40,000 | $5.72 | $229K | 186,872 |
| 2013-01-03 | Demopulos Peter A MD Director | Purchase | +9,345 | $5.42 | $51K | 175,067 |
| 2013-01-03 | HANISH ARNOLD C Director | Purchase | +2,000 | $5.58 | $11K | 2,400 |
| 2012-12-31 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion | +10,000 | $0.98 | $10K | 1,394,301 |
| 2012-12-31 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 388,163 |
Page 22 of 27 · 522 trades